Demaulo, Laufred C.

HRN: 21-46-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFTRIAXONE 1G (VIAL)
06/16/2022
06/23/2022
IV
1gm
Q12
Fracture, Open Reduction
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: